Cancer stem cells in solid tumors: elusive or illusive?

Area of Science:

• Oncology
• Stem Cell Biology
• Cancer Research

Background:

• Tumorigenesis is thought to be driven by rare cancer stem cells (CSCs) with self-renewal and differentiation capabilities.
• The existence and precise definition of CSCs in solid tumors are debated due to challenges in identification and characterization.
• Recent studies question the rarity of tumor-initiating cells, prompting re-evaluation of the CSC hypothesis.

Purpose of the Study:

• To critically review current methods for identifying and characterizing cancer stem cells.
• To discuss the ongoing debate regarding the existence and prevalence of CSCs in solid tumors.
• To explore new perspectives, including the link between CSCs and induced pluripotent stem cells.

Main Methods:

• Review of in vivo transplantation and in vitro colony-forming assays.
• Critical analysis of experimental procedures and findings related to CSCs.
• Discussion of recent research challenging the CSC hypothesis.

Main Results:

• Identification and characterization of CSCs remain challenging due to a lack of stringent definitions and specific markers.
• Evidence suggests that tumor-initiating cells may not be as rare as previously thought under certain experimental conditions.
• The CSC hypothesis for solid tumors is under scrutiny.

Conclusions:

• Further research is needed to establish clear definitions and reliable markers for CSCs in solid tumors.
• The role and abundance of tumor-initiating cells require re-evaluation.
• Exploring connections with induced pluripotent stem cells may offer new insights into cancer stem cell biology.